October 26, 2026
Breaking
Business

Biocon expands global reach of Stelara biosimilar to nine more markets

admin1 min read

The biosimilar to Johnson & Johnson’s Stelara will be commercialised in nine additional markets, expanding Biocon’s global reach in immunology

The post Biocon expands global reach of Stelara biosimilar to nine more markets appeared first on Home Page.

Leave a Comment

Your email address will not be published. Required fields are marked *